Clinical Cardiology Alert – May 1, 2010
May 1, 2010
View Issues
-
Timing of Catheterization in ACS
Non-ST elevation (NSTE) acute coronary syndromes (ACS) can be managed by either an early invasive or early conservative strategy, with most data favoring an early invasive strategy in moderate- and high-risk patients. -
Lenient vs. Strict Rate Control in Patients with AF
The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) study compared two different strategies for rate control in patients with permanent atrial fibrillation. -
Frail Elderly and Cardiac Surgery
Although age is a risk factor for morbidity and mortality with cardiac surgery, chronologic age does not always reflect biological age. Although frailty has been shown to predict falls, hospitalization, institutionalization, and mortality in geriatric populations in the community, it has not been systematically studied in patients undergoing surgery. -
Extraction of Infected Pacemaker/ICD Leads
The number of patients with implantable pacemakers and implantable defibrillators has increased markedly in recent years. Unfortunately, cardiac rhythm device (CRM)-related infections have also increased, and management of these infections is often problematic. -
Reproducibility of Mitral Regurgitation Quantitation
The American Society of Echocardiography (ASE) has recommended that quantitative techniques be used to assess the severity of mitral regurgitation (MR) by echocardiography. -
Non-Dilated Cardiomyopathy
Little is known about the least common of left ventricular (LV) remodeling abnormalities, low ejection fraction (EF) with no cavity dilation or non-dilated cardiomyopathy. -
Transcatheter Aortic Valve Implantation (TAVI) for AS Patients at High Surgical Risk
Surgical aortic valve replacement (SAVR) remains the gold standard treatment for calcific aortic stenosis (AS). However, AS is predominantly a disease of the elderly and, thus, many patients have significant comorbidities that make SAVR very high risk. -
Supplement: Health Care Reform Update
Health care clinicians and organizations likely will find that the new health care reform bill's positive features outweigh its drawbacks, experts say. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.